S.V. Feinman

3.0k citations

36 papers · 2.3k indexed · 1 hit paper · h-index 20

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
Epidemiology top 1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 28
- Hepatitis C virus research 27
Epidemiology 28
- Hepatitis B Virus Studies 25
- Liver Disease Diagnosis and Treatment 20

Co-authors: B. Berris J. Rasenack Amy Lin Stefan Zeuzem E. Jenny Heathcote Edward Gane M. Diago Joseph H. Hoffman
Journals: Gastroenterology (5 papers)Journal of Hepatology (4 papers)Hepatology (3 papers)Digestive Diseases and Sciences (3 papers)The Lancet (3 papers)
Partner nations: Canada United States Poland

In The Last Decade

S.V. Feinman

35 papers receiving 2.2k citations

Hit Papers

align trajectories log scale

Peginterferon Alfa-2a in Patients with Chronic Hepatitis C 2000 · 954 citations

Peers

Countries citing papers authored by S.V. Feinman

Since Specialization

Citations

This map shows the geographic impact of S.V. Feinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.V. Feinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.V. Feinman more than expected).

Fields of papers citing papers by S.V. Feinman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.V. Feinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.V. Feinman. The network helps show where S.V. Feinman may publish in the future.

Co-authors

The 25 scholars most cited alongside S.V. Feinman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with S.V. Feinman Line = papers co-authored together S.V. Feinman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies European Journal of Clinical Microbiology & Infectious Diseases ·Paul Marotta, Robert J. Bailey, Magdy Elkashab, 费小冬, S.V. Feinman, Kevork Peltekian, Marc Poliquin, Helga Witt-Sullivan, Emmanouil Rampakakis, Dong-ming Fu, Curtis Cooper	2016	1
2	Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic Response Hepatology ·Marı́a Buti, Yoav Lurie, Muhammad Aji Aqil Santoso, Н. П. Блохина, Andrzej Horban, G Teuber, Christoph Sarrazin, Akram M. Alashari, S.V. Feinman, Rab Faruqi, Lisa D. Pedicone, Rafael Esteban	2010	52
3	Sustained HBeAg and HBsAg Loss After Long-term Follow-up of HBeAg-Positive Patients Treated With Peginterferon α-2b Gastroenterology ·Erik H.C.J. Buster, Hajo J. Flink, Yılmaz Çakaloğlu, Krzysztof Simon, Jörg Trojan, Fehmı Tabak, M.C. Kenemans van der Velde, S.V. Feinman, Tomasz Mach, Ulus Salih Akarca, Martin Schutten, 高行笠松, Anneke J. van Vuuren, Bettina E. Hansen, Harry L.A. Janssen	2008	300
4	Successful Treatment with Peginterferon alfa-2b of HBeAg-positive HBV Non-Responders to Standard Interferon or Lamivudine The American Journal of Gastroenterology ·Hajo J. Flink, Bettina E. Hansen, E. Jenny Heathcote, S.V. Feinman, Halis Şimşek, Selim Karayalçın, Tomasz Mach, 成妙金, Robert A. de Man, Elke Verhey, Solko W. Schalm, Harry L.A. Janssen	2006	21
5	Twelve weeks of follow-up is sufficient for the determination of sustained virologic response in patients treated with interferon α for chronic hepatitis C Journal of Hepatology ·Stefan Zeuzem, E. Jenny Heathcote, Mitchell L. Shiffman, Teresa L. Wright, Vincent G. Bain, Morris Sherman, S.V. Feinman, Michael Fried, J. Rasenack, Christoph Sarrazin, Donald M. Jensen, Amy Lin, Joseph H. Hoffman, Farhad Sedarati	2003	47
6	Peginterferon ??-2a (40kD) [Pegasys??] Improves HR-QOL Outcomes Compared with Unmodified Interferon ??-2a [Roferon??-A] PharmacoEconomics ·J. Rasenack, Stefan Zeuzem, S.V. Feinman, E. Jenny Heathcote, Michael P. Manns, Eric M. Yoshida, Mark G. Swain, Edward Gane, M. Diago, Dennis A. Revicki, Amy Lin, Neil Wintfeld, Jesse Green	2003	67
7	Peginterferon Alfa-2a in Patients with Chronic Hepatitis C New England Journal of Medicine ·Stefan Zeuzem, S.V. Feinman, J. Rasenack, E. Jenny Heathcote, Ming–Yang Lai, Edward Gane, John O’Grady, Jürg Reichen, M. Diago, Amy Lin, Joseph H. Hoffman, Michael J. Brunda Hit paper breakdown →	2000	954
8	Interferon Treatment of Hepatitis C Associated With Symptoms of PTSD Psychosomatics ·Robert Maunder, Jonathan Hunter, S.V. Feinman	1998	18
9	Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests The Lancet ·M.A. Blajchman, (unknown), Shelley B. Bull, S.V. Feinman	1995	70
10	Interferons for viral hepatitis Transfusion Medicine Reviews ·Norah A. Terrault, S.V. Feinman	1995	3
11	Effects of interferon-? therapy on serum and liver HBV DNA in patients with chronic hepatitis B Digestive Diseases and Sciences ·S.V. Feinman, B. Berris, Roy Sooknanan, J. Fernandes, Nik Gisborne	1992	9
12	Thyroid dysfunction and liver injury following alpha-interferon treatment of chronic viral hepatitis Digestive Diseases and Sciences ·B. Berris, S.V. Feinman	1991	54
13	Posttransfusion hepatitis in Toronto, Canada Gastroenterology ·S.V. Feinman, B. Berris, Nik Gisborne	1988	53
14	Serum HBV-DNA (hepatitis B virus DNA) in acute and chronic hepatitis B infection. PubMed ·S.V. Feinman, B. Berris, Oscar Fay, Roy Sooknanan, Hugo Tanno, D Louis, Harvey M. Lieberman	1988	2
15	Hepatitis B virus DNA in asymptomatic HBsAg carriers: Comparison with HBeAg/anti‐HBe status Journal of Medical Virology ·B. Berris, Richard E. Sampliner, Roy Sooknanan, S.V. Feinman	1987	15
16	Removal of Hepatitis B Surface Antigen from a Contaminated Applanation Tonometer American Journal of Ophthalmology ·L. Mangin, F. Feldman, Marianna M. Newkirk, S.V. Feinman, B. Berris	1981	19
17	Inability to detect hepatitis B surface antigen (HBsAg) in the duodenum of HBsAg-positive persons Digestive Diseases and Sciences ·S.V. Feinman, B. Berris, Yyf Wong, S.A. Wilson, A. N. Tsar’kov	1981	1
18	Hepatitis and hepatitis B surface antigen and antibody in dentists. PubMed ·B. Berris, S.V. Feinman, Josiah Sinclair, Jenny Deluty	1978	11
19	Diseases of the Liver and Biliary Tract Canadian Medical Association Journal ·B. Berris, S.V. Feinman	1977	54
20	e ANTIGEN AND ANTI-e IN HBsAg CARRIERS The Lancet ·S.V. Feinman, B. Berris, Josiah Sinclair, Jenny Deluty, Brittany L. Murphy, James E. Maynard	1975	50

About S.V. Feinman

S.V. Feinman is a scholar working on Hepatology, Epidemiology, General Dentistry, Rheumatology and Infectious Diseases, having authored 36 papers that have together received 2.3k indexed citations. Recurring topics across this work include Hepatitis C virus research (27 papers), Hepatitis B Virus Studies (25 papers), Liver Disease Diagnosis and Treatment (20 papers), Systemic Lupus Erythematosus Research (4 papers), Viral gastroenteritis research and epidemiology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Retinal and Optic Conditions (1 paper) and Pancreatic and Hepatic Oncology Research (1 paper). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (1.8k citations), Rheumatology (199 citations), Infectious Diseases (194 citations) and Virology (38 citations). S.V. Feinman has collaborated with scholars based in Canada, United States and Poland. Frequent co-authors include B. Berris, J. Rasenack, Amy Lin, Stefan Zeuzem, E. Jenny Heathcote, Edward Gane, M. Diago, Joseph H. Hoffman, Michael J. Brunda and Jürg Reichen. Their work appears in journals such as Gastroenterology, Journal of Hepatology, Hepatology, Digestive Diseases and Sciences and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact